DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Abou-Alfa G, Amadori D, Santoro A. et al.
Is sorafenib (S) safe and effective in patients (pts) with hepatocellular carcinoma (HCC) and Child-Pugh B (CPB) cirrhosis?
J Clin Oncol 2008; 26(Suppl): A4518-
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.